Search

everythinglearnresearchcommunity

for

Search:↓

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Menopause affects hair and skin; more research needed for treatment.

Men with testicular cancer were less likely to experience baldness and severe acne.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

New compounds may soon be tested to treat excessive hair growth in women.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

New compounds were found to help increase hair growth and decrease hair loss.

ESR2 gene variations may be linked to female pattern hair loss.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Researchers developed a method to grow hair follicle cells for transplantation using a special chip.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Male pattern hair loss negatively affects quality of life, but drug treatments can help.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.